BJCM
BIIB icon

Blue Jay Capital Management’s Biogen BIIB Stock Holding History

Blue Jay Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-46,320
Closed -$12.7M – 21
2017
Q1 		$12.7M Buy
+46,320
New +$13.1M 6.23% 2
2016
Q4 		– Sell
-40,996
Closed -$12.8M – 16
2016
Q3 		$12.8M Buy
40,996
+996
+2% +$295K 7.01% 1
2016
Q2 		$9.67M Buy
+40,000
New +$10.5M 6.35% 11
2016
Q1 		– Sell
-58,161
Closed -$17.8M – 18
2015
Q4 		$17.8M Buy
58,161
+15,661
+37% +$4.5M 6.01% 4
2015
Q3 		$12.4M Buy
+42,500
New +$14M 4.87% 14
2015
Q1 		– Sell
-32,500
Closed -$11M – 22
2014
Q4 		$11M Buy
+32,500
New +$10.5M 4.92% 7

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Blue Jay Capital Management's BIIB Position: Q2 2017 in Review

Blue Jay Capital Management sold out of Biogen (BIIB) in Q2 2017, closing a stake of 46,320 shares — an estimated $12.7M sold.

Blue Jay Capital Management first reported a position in BIIB in Q4 2014 and held it in 6 quarters. The position peaked at $17.8M in Q4 2015. 993 funds tracked by Wall St. Rank hold BIIB as of Q2 2017.

  • Blue Jay Capital Management reported no remaining Biogen position as of Q2 2017 after selling out during the quarter.
  • Blue Jay Capital Management sold 46,320 Biogen shares in Q2 2017, an estimated $12.7M.
  • Blue Jay Capital Management first reported a position in Biogen in Q4 2014 and held it in 6 quarters.
  • Blue Jay Capital Management's Biogen position peaked at $17.8M in Q4 2015.
  • 993 funds tracked by Wall St. Rank held Biogen as of Q2 2017.

Based on Blue Jay Capital Management's 13F filing for Q2 2017, filed 11 Aug 2017.